Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Advances in Human Augmentation: We Can Rebuild Him

By Olga Kharif - 2012-03-07T02:05:27Z

Courtesy MicroCHIPS Inc.

Company Symbol % Change
9 of 16

Daily Dose

MicroCHIPS Inc.

The MicroCHIPs is another implantable device--this one capable of delivering a daily dose of medicines and communicating wirelessly to allow data transmission and remote control. It is implanted under the skin in a simple outpatient procedure using local anesthesia, through a small incision. On Feb. 16, MicroCHIPS announced the results of its first successful human clinical trial, in which the device was used to provide daily doses to women with osteoporosis. The company plans to file for regulatory approval for its first microchip device in 2014.